RxDoctor Payments Data

Jonathan Owens, MD

Otolaryngology · New Orleans, LANPI 1639110109

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (49.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Intersect ENT, Inc. at 31.2% of the total. Among otolaryngology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,417in general payments, 2019–2025

Across 65 payments — averaging $114.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$2K
  • Medtronic$2K
  • Medical Device Business Services, Inc.$1K
  • Cochlear Americas$574
  • Verathon Inc.$550
  • Sanofi$255
  • plus $633 from 11 others

What the payments were for

  • Consulting fees$5507%
  • Travel & lodging$3,64249%
  • Food & beverage$3,22043%
  • Gifts$40%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,417 in reported general payments places this provider in the 90th percentile of 218 otolaryngology providers in Louisiana.

See all otolaryngology providers in Louisiana

Medicare billing

Part B allowed, 2024
$18,379
Medicare patients
103
Services billed
204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate40$934
Fluocinolone Acetonide14$299
Omeprazole19$156
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$96
Prednisone13$39

Paid to pharmacies, not to this prescriber.

Other otolaryngology in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →